J9211 Idarubicin hcl injection
Also known as: idarubicin, Idamycin
Intravenous injection of idarubicin hydrochloride, an anthracycline topoisomerase II inhibitor.
In Plain Language
red chemotherapy drug; acute leukemia treatment
Clinical Context
Used for acute myeloid leukemia and acute lymphoblastic leukemia.
RVU Information
CPT J9211 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9211?
CPT J9211 (Idarubicin hcl injection) is a J Codes (Drugs) code. Intravenous injection of idarubicin hydrochloride, an anthracycline topoisomerase II inhibitor.
How is J9211 administered?
CPT J9211 is administered by a healthcare provider, typically via injection or infusion. Used for acute myeloid leukemia and acute lymphoblastic leukemia. It is used by Hematology/Oncology, Medical Oncology.
When is CPT J9211 used?
Used for acute myeloid leukemia and acute lymphoblastic leukemia.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.